ATS View
한국어

Yuyu Pharma KRX:000220KOSPI

유유제약 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h6
Articles, 7 days21
DART filings, 7 days0
Articles tracked21since Sep 11

In Q2 2026, Yuyu Pharma reported revenue of ₩36.7bn, up 2.4% year on year, and operating profit of ₩4.0bn. Yuyu Pharma (유유제약) appeared in 21 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 21 articles. The most common catalyst was risk & warnings (1). It was most often mentioned alongside Tdspharm.

Yuyu Pharma quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩36.7bn+2.4%₩4.0bn₩3.6bn
Q1 2026₩35.5bn+8.0%₩4.3bn₩3.4bn
Q4 2025 derived₩34.3bn+4.2%−₩129m₩1.2bn
Q3 2025₩37.8bn+12.5%₩5.0bn₩4.3bn
Q2 2025₩35.8bn+8.0%₩2.2bn₩592m
Q1 2025₩32.9bn-1.5%₩3.9bn₩3.0bn
Q4 2024 derived₩33.0bn-4.7%−₩268m−₩605m
Q3 2024₩33.6bn-1.4%₩3.5bn₩3.3bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Yuyu Pharma top stories 2 weeks, by number of outlets

  1. 1
    유유제약, 제천공장에 신규 태양광 발전설비 설치
    6 outlets · 6 articlesFirst report Sep 14 08:06 아시아경제
  2. 2
    유유제약, 제천공장에 태양광 발전…소비전력 30% 담당 기대
    3 outlets · 3 articlesFirst report Sep 14 08:36 메디파나뉴스
  3. 3
    유유제약, 제천공장 태양광 설비 확대…소비전력 30% 충당
    3 outlets · 3 articlesFirst report Sep 14 08:36 머니투데이
  4. 4
    유유제약, 태양광 발전으로 기업경쟁력 강화
    2 outlets · 2 articlesFirst report Sep 14 09:14 뉴스타운
  5. 5
    유유제약 타나민 4품목 제조정지…티디에스팜 과징금 1935만원
    1 outlets · 1 articlesFirst report Sep 14 06:15 뉴스더보이스헬스케어Negative newsTdspharm
  6. 6
    유유제약, ‘제천공장’ 태양광 발전설비 설치…“공장 소비전력 30% 담당”
    1 outlets · 1 articlesFirst report Sep 14 11:23 더바이오

Latest Yuyu Pharma news Korean headlines